Urology
Volume 75, Issue 5 , Pages 1004-1008, May 2010

Reduction in Patient-reported Acute Morbidity in Prostate Cancer Patients Treated With 81-Gy Intensity-modulated Radiotherapy Using Reduced Planning Target Volume Margins and Electromagnetic Tracking: Assessing the Impact of Margin Reduction Study

Presented at the 51st annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 1-4, 2009.

  • Howard M. Sandler

      Affiliations

    • Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California
    • Corresponding Author InformationReprint requests: Howard M. Sandler, M.D., M.S., Department of Radiation Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048
    • ,
  • Ping-Yu Liu

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Rodney L. Dunn

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • ,
  • David C. Khan

      Affiliations

    • 21st Century Oncology, Santa Monica, California
    • ,
  • Scott E. Tropper

      Affiliations

    • 21st Century Oncology, Scottsdale, Arizona
    • ,
  • Martin G. Sanda

      Affiliations

    • Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
    • ,
  • Constantine A. Mantz

      Affiliations

    • 21st Century Oncology, Cape Coral, Florida

Received 24 September 2009; accepted 25 October 2009. published online 15 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Calypso Medical Technologies, Inc. and NIH R01CA 95662.

 P-Y Liu, and R.L. Dunn, are paid statistical consultants for Calypso Medical Technologies, Inc.

PII: S0090-4295(09)03007-6

doi:10.1016/j.urology.2009.10.072

Urology
Volume 75, Issue 5 , Pages 1004-1008, May 2010

Article Tools